Novartis Ag (NVS) Selling, General & Administrative (2009 - 2026)
Novartis Ag's Selling, General & Administrative came in at -$3.24 billion for Q2 2026, compared with -$3.44 billion a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Selling, General & Administrative of -$13.13 billion; for FY2025, it was -$13.25 billion.
- Going back by year, Selling, General & Administrative was -$12.57 billion in FY2024, -$12.52 billion in FY2023, -$12.19 billion in FY2022 and -$12.83 billion in FY2021.
- The five-year range for quarterly Selling, General & Administrative is -$3.99 billion (Q4 2021) to -$2.84 billion (Q1 2024).
- Business Quant data shows NVS's Selling, General & Administrative at -$3.14 billion (Q1 2026), -$3.44 billion (Q4 2025) and -$3.31 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 582.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.24 Bn |
| Mar 31, 2026 | -3.14 Bn |
| Dec 31, 2025 | -3.44 Bn |
| Sep 30, 2025 | -3.31 Bn |
| Jun 30, 2025 | -3.44 Bn |
| Mar 31, 2025 | -3.06 Bn |
| Dec 31, 2024 | -3.50 Bn |
| Sep 30, 2024 | -3.13 Bn |
| Jun 30, 2024 | -3.09 Bn |
| Mar 31, 2024 | -2.84 Bn |
| Dec 31, 2023 | -3.44 Bn |
| Sep 30, 2023 | -3.09 Bn |
| Jun 30, 2023 | -3.09 Bn |
| Mar 31, 2023 | -2.89 Bn |
| Dec 31, 2022 | -3.18 Bn |
| Sep 30, 2022 | -2.94 Bn |
| Jun 30, 2022 | -3.58 Bn |
| Mar 31, 2022 | -3.51 Bn |
| Dec 31, 2021 | -3.99 Bn |
| Sep 30, 2021 | -3.62 Bn |
API Access
Novartis Ag Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();